Upbeat on IT, pharma, autos; see mkt subdued in near-term:UTI MF

The fund is still upbeat on IT and pharma sector even though IT space is still not out of woods but it is likely to be sector that would report profitability going forward. The house is already overweight on pharma, said V Srivatsa, EVP & Fund Manager, UTI Mutual Fund.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney master your money IThe Winning Leap SME Special
Moneycontrol

Home » News » Mutual Funds » MF-Interview

Dec 02, 2016, 12.47 PM | Source: CNBC-TV18

Upbeat on IT, pharma, autos; see mkt subdued in near-term:UTI MF

The fund is still upbeat on IT and pharma sector even though IT space is still not out of woods but it is likely to be sector that would report profitability going forward. The house is already overweight on pharma, said V Srivatsa, EVP & Fund Manager, UTI Mutual Fund.

Like this story, share it with millions of investors on M3

Upbeat on IT, pharma, autos; see mkt subdued in near-term:UTI MF

The fund is still upbeat on IT and pharma sector even though IT space is still not out of woods but it is likely to be sector that would report profitability going forward. The house is already overweight on pharma, said V Srivatsa, EVP & Fund Manager, UTI Mutual Fund.

Post Your Comments

Share Cancel

V Srivatsa (more)

, UTI MF |

V Srivatsa, EVP & Fund Manager, UTI Mutual Fund is of the belief that market would continue to witness minor correction because nobody can assess the full impact of demonetisation as of now. Investors are in a wait-and-watch mode.

Globally too, interest rates are going up and so money is flowing out from risky assets to safer assets. So, the market will remain subdued with a negative bias for the next couple of quarters, says Srivatsa.

With crude oil prices too on an uptick, the house would prefer to play the theme through utilities, which are indirect beneficiaries than pure upstream companies. According to Srivatsa, the case for investing in utilities is that valuations are at a record low and is a space that is less impacted by demonetisation.

The fund is still upbeat on IT and pharma sector even though IT space is still not out of woods but it is likely to be the sector that would report profitability going forward. The house is already overweight on pharma but would still invest in it, says Srivtsa.

The fund is also overweight on auto sector although there would be a near-term impact on it due to demonetisation. But Srivatsa believes that the demand has just been postponed and not been destructed. After seeing poor sales growth for the next 1-2 quarters, pent-up demand would compensate for the loss, believes Srivatsa.

Moreover, the auto ancillaries will face the brunt of demonetisation impact same as the auto space, says Srivatsa.

For the entire discussion, watch video

Q UTI was the only mutual fund for the period of:
Buy, Hold, Sell ? Hear it first on M3
Upbeat on IT, pharma, autos; see mkt subdued in near-term:UTI MF

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login